5 Best Healthcare Stocks to Buy According to Greg Martinez’s Parkman Healthcare Partners
In this article, we discuss the 5 best healthcare stocks to buy according to Greg Martinez's Parkman Healthcare Partners.
Posts Tagged ‘NASDAQ:UTHR’
Were Hedge Funds Right About Piling Into United Therapeutics Corporation (UTHR)?
At Insider Monkey, we pore over the filings of nearly 873 top investment firms every quarter, a process we have now completed for the latest reporting period.
Dov Gertzulin Portfolio: Top 5 Stocks
In this article, we discuss the top 5 stocks in Dov Gertzulin's portfolio.
Richard Pzena’s 9 New Stock Picks
In this article, we discuss Richard Pzena’s 9 new stock picks.
15 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will take a look at 15 biotech and pharmaceutical stocks to buy according to Palo Alto Investors.
Hedge Funds Are Crazy About United Therapeutics Corporation (UTHR)
With the second-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Hedge Funds Have Never Been This Bullish On United Therapeutics Corporation (UTHR)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
Is UTHR Stock A Buy or Sell?
In this article we will check out the progression of hedge fund sentiment towards United Therapeutics Corporation (NASDAQ:UTHR) and determine whether it is a good investment right...
Is UTHR A Good Stock To Buy Now?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Was The Smart Money Right About United Therapeutics Corporation (UTHR)?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Hedge Funds Are Absolutely Crazy About United Therapeutics Corporation (UTHR)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Did Hedge Funds Make The Right Call On United Therapeutics Corporation (UTHR) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Should You Avoid United Therapeutics Corporation (UTHR)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On United Therapeutics Corporation (UTHR)
We hate to say this but, we told you so.
Hedge Fund Favorites vs. United Therapeutics Corporation (UTHR) In 2019
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
United Therapeutics (UTHR): Hedge Funds Were Patiently Waiting For Strong Gains
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
United Therapeutics Corporation (UTHR): Hedge Funds Had A Change of Heart
A whopping number of 13F filings filed with U.S.
Here’s What Hedge Funds Think About United Therapeutics Corporation (UTHR)
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Tiger Global because we determined that some of the ...
Is United Therapeutics Corporation (UTHR) A Good Stock To Buy?
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited...
United Therapeutics Corporation (UTHR): Are Hedge Funds Right About This Stock?
"Market volatility has picked up again over the past few weeks.
Should You Buy United Therapeutics Corporation (UTHR)?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Palo Alto Investors’s Bets on ABIOMED, Inc. (ABMD), United Therapeutics Corporation (UTHR) and Other Stocks Lift Its Q3 Returns
Palo Alto Investors was founded by William Leland Edwards in 1989. The fund usually invests in companies with market capitalization less than $3 billion.
Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments.
Palo Alto’s Top Picks for This Year Following Impressive 2015 Returns
William Leland Edwards' Palo Alto Investors has about $2.22 billion worth of regulatory assets under its management.
Top Stock Picks of Multi-Billion Dollar, Healthcare-Focused Fund Palo Alto Investors
Palo Alto Investors, founded by Wall Street veteran William Leland Edwards in 1989, is one of the biggest healthcare investment shops in the United States, with over $2 billion...
How Smart Money Is Trading United Therapeutics Corporation (UTHR)
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
United Therapeutics Corporation (UTHR), Amgen, Inc. (AMGN): Neil Shah’s Top Healthcare Picks Dominated S&P 500 Index in January-March
March Altus Capital Management, headquartered in Greenwich, Connecticut, was founded by Neil Shah in December 2011.This healthcare focused fund follows bottom-up fundamental analysis...
Era Group Inc (ERA), BioMarin Pharmaceutical Inc. (BMRN), & Assured Guaranty Ltd. (AGO) Among Stocks Amici Capital Is Bullish on
Paul Orlin's Amici Capital has increased its exposure to Era Group Inc (NYSE:ERA), as a new filing with the Securities and Exchange Commission shows.
Palo Alto Rejoicing at ABIOMED, Inc. (ABMD)’s 18% Spike
ABIOMED, Inc. (NASDAQ:ABMD) spiked as high as 21% in Tuesday's intraday trading to eventually close at 18% in the green at $72.48.
Akorn, Inc. (AKRX), United Therapeutics Corporation (UTHR) Among Consonance Capital’s Winning Bets in Healthcare
The $5.50 billion pharmaceutical company Akorn, Inc. (NASDAQ:AKRX) was one of the top gainers on Wednesday, closing the session with an almost 10% gain.
Amicus Therapeutics Inc. (FOLD): Palo Alto Investors Sells Half of its Stake At Sky-High Valuation
William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD).
InterMune Inc (ITMN), United Therapeutics Corporation (UTHR), Cyberonics Inc. (CYBX): Palo Alto Investors Loves Healthcare Stocks
Palo Alto Investors is a hedge fund founded by William Leland Edwards in 1989, and managed by him ever since.
Consonance Capital Management is Fond of Healthcare Stocks
Consonance Capital Management is a New York based hedge fund established in 2005, managed by Mitchell Blutt MD.
Joel Greenblatt’s Top Picks Include United Therapeutics and Activision Blizzard
One of the funds we track is Joel Greenblatt's Gotham Asset Management, which recently filed its 13F form, disclosing its equity portfolio as at the end of the third quarter ...
Hedge Funds Are Dumping Dr. Reddy’s Laboratories Limited (ADR) (RDY)
To many of your fellow Dr.
Pfizer Inc. (PFE): Arena Pharmaceuticals, Inc. (ARNA) Pushes Forward
As much as I think Arena Pharmaceuticals, Inc.
Hedge Funds Are Betting On United Therapeutics Corporation (UTHR)
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age.
What Hedge Funds Think About Pharmacyclics, Inc. (PCYC)
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies.
The Medicines Company (MDCO), United Therapeutics Corporation (UTHR): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
In the eyes of many investors, hedge funds are perceived as bloated, outdated financial vehicles of a forgotten age.
Hedge Funds Are Crazy About Endo Health Solutions Inc (ENDP)
To many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten age.
Hedge Funds Are Betting On Warner Chilcott Plc (WCRX)
In today’s marketplace, there are tons of indicators investors can use to track the equity markets.
Cubist Pharmaceuticals Inc (CBST): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time.
Pfizer Inc. (PFE), United Therapeutics Corporation (UTHR): How Big Is Organovo Holdings Inc (ONVO)’s Market Opportunity?
Organovo Holdings Inc (NYSEMKT:ONVO) is a little company that people think could do big things.
Pfizer Inc. (PFE), United Therapeutics Corporation (UTHR): Organovo Holdings Inc (ONVO)’s Earnings, Patience Is Necessary
Imagine a day where there are no waiting lists for liver transplants. Instead, patients can have a perfectly tailored liver bioprinted and placed into their body.
‘Magic Formula Man’ Is Crazy About Warner Chilcott Plc (WCRX) & United Therapeutics Corporation (UTHR)
Joel Greenblatt's hedge fund, Gotham Asset Management, is one of the institutional investors who recently filed their Q2 13F form with the Securities and Exchange Commission.
Organovo Holdings Inc (ONVO), 3D Systems Corporation (DDD): A Tiny 3-D Printing Company I’m Buying
Ever since August 2011, I've been calling out one or two companies every month that I was putting my own retirement money behind.
Taro Pharmaceutical Industries Ltd. (TARO): Insiders Aren’t Crazy About It
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was in 8 hedge funds' portfolio at the end of March.
Is United Therapeutics Corporation (UTHR) Going to Burn These Hedge Funds?
If you'd ask most investors, hedge funds are perceived as slow, old investment tools of the past.
Should You Buy The Medicines Company (MDCO)?
At the moment, there are a multitude of metrics investors can use to analyze their holdings. A duo of the most under-the-radar are hedge fund and insider trading activity.
Is Pharmacyclics, Inc. (PCYC) Going to Burn These Hedge Funds?
To most shareholders, hedge funds are perceived as unimportant, outdated investment vehicles of years past.
